Current Report
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
________
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
|
Date
of report (Date of earliest event reported): March 11,
2008
|
|
|
|
JPMORGAN
CHASE & CO.
|
|
(Exact
Name of Registrant
as
Specified in Charter)
|
|
|
|
|
DELAWARE
|
|
|
|
(State
or Other Jurisdiction of Incorporation)
|
|
|
|
|
001-05805
|
|
13-2624428
|
|
(Commission
File Number)
|
|
(IRS
Employer Identification No.)
|
|
|
|
270
Park Avenue,
New
York, NY
|
|
10017
|
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
|
|
|
|
|
|
|
Registrant’s
telephone number, including area code:
(212)
270-6000
|
|
|
|
|
|
___________________________
|
|
|
|
|
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
|
|
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
|
|
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
|
|
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
9.01. Financial Statements and Exhibits
(d) Exhibits
The
following Exhibits are incorporated by reference into the Registration Statement
on Form S-3ASR (333-130051) of JPMorgan Chase & Co. (the “Registrant”) as
exhibits thereto and are filed as part of this Current Report.
|
8.1
|
Tax
Opinion of Davis Polk & Wardwell relating to Buffered Return Enhanced
Notes Linked to the S&P 500
®
Index due June 16, 2008
|
|
8.2
|
Tax
Opinion of Davis Polk & Wardwell relating to Resetting Reverse
Exchangeable Notes Linked to the Common Stock of a Reference Stock
Issuer
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
JPMORGAN
CHASE & CO.
(Registrant)
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/
Neila B. Radin
|
|
|
|
|
|
|
|
|
|
|
Name:
|
Neila
B. Radin
|
|
|
|
|
Title:
|
Senior
Vice President
|
|
Dated:
March 13, 2008
EXHIBIT
INDEX
|
|
|
|
8.1
|
Tax
Opinion of Davis Polk & Wardwell relating to Buffered Return Enhanced
Notes Linked to the S&P 500
®
Index due June 16, 2008
|
|
8.2
|
Tax
Opinion of Davis Polk & Wardwell relating to Resetting Reverse
Exchangeable Notes Linked to the Common Stock of a Reference Stock
Issuer
|
Exhibit
8.1
DAVIS POLK
& WARDWELL
450
LEXINGTON AVENUE
NEW YORK,
NEW YORK 10017
270 Park
Avenue
New York,
New York 10017
Ladies and
Gentlemen:
We have acted as special tax counsel to
JPMorgan Chase & Co., a corporation incorporated under the laws of Delaware
(the “Company”), in connection with the preparation and filing of pricing
supplement no. 1081 dated March 11, 2008 relatin
g to
Buffered Return Enhanced
Notes Linked to the S&P 500
®
Index
due June 16, 2008
(the “Pricing Supplement”) to product
supplement no. 39-VIII dated December 14, 2007 relating to
Return
Enhanced Notes Linked to a Weighted Basket Consisting of the S&P 500
®
Index,
the S&P BRIC 40 Index, the Nikkei 225 Index, the Dow Jones EURO STOXX
50
®
Index, the Dow Jones U.S. Real Estate Index, the Dow Jones — AIG Commodity
Index
SM
, the
FTSE™ 100 Index, the MSCI EAFE
®
Index,
the NASDAQ-100 Index
®
, the
Russell 1000
®
Growth
Index, the Russell 1000
®
Value
Index, the Russell 2000
®
Index,
the iShares
®
MSCI
Emerging Markets Index Fund and the Vanguard
®
Emerging
Markets ETF (the “Product Supplement”) to a prospectus supplement dated October
12, 2006 (the “Prospectus Supplement”) for the Company’s Global Medium-Term
Notes, Series E, Global Warrants, Series E and Global Units, Series E, relating
to a prospectus dated December 1, 2005 (the “Prospectus”) contained in the
Company’s Registration Statement on Form S-3ASR (Registration Statement No.
333-130051) (the “Registration Statement”). This opinion is being
furnished in accordance with the requirements of Section 601(b)(8) of Regulation
S-K of the Securities Act of 1933, as amended (the “Act”).
In our opinion, the discussions under
the heading “United States Federal Taxation” in the Prospectus Supplement, under
the heading “Certain U.S. Federal Income Tax Consequences” in the Product
Supplement and under the heading “Selected Purchase Considerations –
Capital Gains Tax Treatment” in the
Pricing Supplement
, subject to the conditions and limitations described
therein, set forth the material U.S. federal income tax considerations
applicable generally to holders of the securities offered pursuant to the
Pricing Supplement as a result of the ownership and disposition of such
securities.
We hereby consent to the filing of this
opinion as an exhibit to the Registration Statement and to the references to us
under the heading “United States Federal Taxation” in the Prospectus Supplement,
under the heading “Certain U.S. Federal Income Tax Consequences” in the Product
Supplement and under the heading “Selected Purchase Considerations –
Capital Gains Tax Treatment” in the
Pricing Supplement
. By such consent we do not concede that we
are an “expert” for the purposes of the Act.
|
|
Very
truly yours,
|
|
|
|
|
|
/s/
Davis Polk & Wardwell
|
Exhibit
8.2
DAVIS POLK
& WARDWELL
450
LEXINGTON AVENUE
NEW YORK,
NEW YORK 10017
270 Park
Avenue
New York,
New York 10017
Ladies and
Gentlemen:
We have acted as special tax counsel to
JPMorgan Chase & Co., a corporation incorporated under the laws of Delaware
(the “Company”), in connection with the preparation and filing of
product supplement no. 126-I dated March
13, 2008 relating to
Resetting Reverse Exchangeable Notes Linked to the
Common Stock of a Reference Stock Issuer (the “Product Supplement”) to a
prospectus supplement dated October 12, 2006 (the “Prospectus Supplement”) for
the Company’s Global Medium-Term Notes, Series E, Global Warrants, Series E and
Global Units, Series E, relating to a prospectus dated December 1, 2005 (the
“Prospectus”) contained in the Company’s Registration Statement on Form S-3ASR
(Registration Statement No. 333-130051) (the “Registration
Statement”). This opinion is being furnished in accordance with the
requirements of Section 601(b)(8) of Regulation S-K of the Securities Act of
1933, as amended (the “Act”).
In our opinion, the discussions under
the heading “United States Federal Taxation” in the Prospectus Supplement and
under the heading “Certain U.S. Federal Tax Consequences” in the Product
Supplement, subject to the conditions and limitations described therein, set
forth the material U.S. federal income tax considerations applicable generally
to holders of the securities to be offered pursuant to the Product Supplement as
a result of the ownership and disposition of such securities.
We hereby consent to the filing of this
opinion as an exhibit to the Registration Statement and to the references to us
under the heading “United States Federal Taxation” in the Prospectus Supplement
and under the heading “Certain U.S. Federal Tax Consequences” in the Product
Supplement. By such consent we do not concede that we are an “expert”
for the purposes of the Act.
|
|
Very
truly yours,
|
|
|
|
|
|
/s/
Davis Polk & Wardwell
|